SCHEMBL8273374

SCHEMBL8273374

CO[C@@H](C(=O)NCC1CCN(c2ccc(F)cc2N)CC1)[C@@H](O)C(=O)N1CCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.40
▸ HTT P42858 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ KDM4E B2RXH2 4/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ HTR4 Q13639 1/20 0.37
▸ PDE6D O43924 1/20 0.37
▸ HRAS P01112 1/20 0.37
▸ KRAS P01116 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ HDAC3 O15379 2/20 0.35
▸ HDAC1 Q13547 2/20 0.35
▸ HDAC2 Q92769 2/20 0.35
▸ ADAM17 P78536 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8273376 0.93 ALDH1A1 (0.40) ALDH1A1HTTGAAKDM4ENPC1
SCHEMBL8273310 0.89 GAA (0.44) ALDH1A1HTTGAAKDM4ENPC1
SCHEMBL8273592 0.88 HTT (0.46) ALDH1A1HTTGAAKDM4ENPC1
SCHEMBL8218105 0.88 ADAM17 (0.44) ALDH1A1KDM4EMAPTHPGDKMT2A
SCHEMBL8273591 0.87 ADAM17 (0.43) ALDH1A1HTTGAAKDM4ENPC1
SCHEMBL8274681 0.84 GAA (0.43) ALDH1A1HTTGAAKDM4ENPC1
SCHEMBL8275455 0.83 ALDH1A1 (0.36) ALDH1A1HTTGAAKDM4ENPC1
SCHEMBL8273579 0.81 CTSS (0.41) ALDH1A1HTTGAAKDM4EKMT2A
SCHEMBL8273588 0.81 ADAM17 (0.40) ALDH1A1HTTGAAKDM4ENPC1
SCHEMBL8218112 0.81 ADAM17 (0.46) KMT2AADAM17NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005121130-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2005-12-22 — — WO disclosed
Send feedback